prescription antiemetics if persistent
Clinical trials show GLP-1 receptor agonists reduce waist circumference by approximately 13.5 cm with semaglutide after 68 weeks, with imaging studies demonstrating significant decreases in visceral adipose tissue volume
The SEMALEAN trial found lean mass declined then stabilised while handgrip strength improved by 4.5 kg and sarcopenic obesity prevalence fell from 49% to 33% over twelve months
Sirohi, S., Schurdak, J
Blum, are going beyond the scale and leaning more heavily into the potential healthspan and longevity benefits
We are proud to be a leading provider of peptide therapy in McLean, VA, serving the surrounding areas of Northern Virginia and Washington, D.C., including Tysons Corner, Arlington, Falls Church, Great Falls, Fairfax County, and Vienna